Originalsprog | Engelsk |
---|---|
Artikelnummer | e126 |
Tidsskrift | HemaSphere |
Vol/bind | 8 |
Udgave nummer | 7 |
Antal sider | 5 |
ISSN | 2572-9241 |
DOI |
|
Status | Udgivet - jul. 2024 |
The role of trephine bone marrow biopsies in the era of measurable residual disease: Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
Nadine Kutsch*, Sandra Robrecht, Anna Fink, Elisabeth Lange, Rudolf Weide, Michael G. Kiehl, Martin Sökler, Rudolf Schlag, Ursula Vehling-Kaiser, Georg Köchling, Christoph Plöger, Michael Gregor, Torben Plesner, Michael R. Clausen, Ilske Oschlies, Matthias Ritgen, Marco Herling, Kirsten Fischer, Hartmut Döhner, Clemens Martin Wendtner
*Kontaktforfatter
- University of Cologne
- Evangelical Hospital Hamm
- Practice for Hematology and Oncology
- Frankfurt (Oder) General Hospital
- University Hospital Tübingen
- Hospital STS AG Thun
- Practice for Oncology and Hematology
- Dayclinic Landshut
- Private Oncology Practice
- Private Oncology Practice
- Lucerne Cantonal Hospital
- Christian-Albrechts-University of Kiel
- University Medical Center Schleswig-Holstein
- Leipzig University Hospital
- University Hospital Ulm
- Ludwig-Maximilian University of Munich
- Rostock University Medical Center
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review